The Kircher lab at Memorial Sloan Kettering is developing novel nanoprobes for molecular imaging, image-guided therapy, and theranostics. Our ultimate goal is to develop a universal technology that allows determination of the total tumor burden in a patient before, during, and after treatment. This will allow detection of both the primary tumor, as well as metastases, both pre- and intraoperatively.
Moritz F. Kircher, MD, PhD
Research FocusPhysician-scientist Moritz Kircher develops novel molecular imaging approaches with a focus on surface-enhanced Raman spectroscopy and magnetic resonance imaging.
- Harmsen S, Huang R, Wall MA, Karabeber H, Samii JM, Spaliviero M, White JR, Monette S, O’Connor R, Pitter KL, Sastra SA, Saborowski M, Holland EC, Singer S, Olive KP, Lowe S, Blasberg R, Kircher MF: Surface-enhanced resonance Raman scattering nanostars for high-precision cancer imaging. Science Translational Medicine. 2015 Jan 21; 7:(271): 271ra7. doi: 10.1126/scitranslmed.3010633
Cover, January issue
- Harmsen S, Bedics MA, Wall MA, Huang R, Detty MR, Kircher MF: Rational Design of a Chalcogenopyrylium-Based Surface-Enhanced Resonance Raman Scattering-Nanoprobe with Attomolar Sensitivity. Nature Communications. 2015 Mar 24;6:6570. doi: 10.1038/ncomms7570.
- Research Scholar Award, Radiological Society of North America (2011)
- Roentgen Resident Research Award, Radiological Society of North America (2008)
- Lawrie B. Morrison Research Award, Harvard Medical School (2007)
- Chief Resident in Radiology, Harvard Medical School (2007)
- Eduard Ceraldi Award, Cleveland Clinic Health System (2005)
- Research Fellow Trainee Prize, Radiological Society of North America (2002 & 2003)